Skip to main content
. 2021 Feb 26;26(5):1271. doi: 10.3390/molecules26051271

Figure 19.

Figure 19

Schematic diagrams illustrating the PBPK model for mPEG-PCL NPs, including mononuclear phagocytic system in organs represented as “MPS” and enhanced permeability and retention in tumours represented as “EPR.” Arrows indicate the direction of transport of mPEG-PCL NPs, while grey boxes indicate the uptake of mPEG-PCL NPs by MPS or EPR from blood circulation or tissues.